Literature DB >> 32772272

Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer.

Giuliano Ciarimboli1, Gerit Theil2, Joanna Bialek2, Bayram Edemir3.   

Abstract

The body homeostasis is maintained mainly by the function of the kidneys, which regulate salt and water balance and excretion of metabolism waste products and xenobiotics. This important renal function is determined by the action of many transport systems, which are specifically expressed in the different parts of the nephron, the functional unit of the kidneys. These transport systems are involved, for example, in the reabsorption of sodium, glucose, and other important solutes and peptides from the primary urine. They are also important in the reabsorption of water and thereby production of a concentrated urine. However, several studies have shown the importance of transport systems for different tumor entities. Transport systems, for example, contributed to the proliferation and migration of cancer cells and thereby on tumor progression. They could also serve as drug transporters that could enable drug resistance by outward transport of, for example, chemotherapeutic agents and other drugs. Although many renal transporters have been characterized in detail with respect to the significance for proper kidney function, their role in renal cancer progression is less known. Here, we describe the types of renal cancer and review the studies that analyzed the role of organic cation transporters of the SLC22-family and of the aquaporin water channel family in kidney tumors.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Aquaporin; Organic cation transporter; Renal cancer

Mesh:

Substances:

Year:  2021        PMID: 32772272     DOI: 10.1007/112_2020_34

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  93 in total

Review 1.  Renal cancer.

Authors:  Umberto Capitanio; Francesco Montorsi
Journal:  Lancet       Date:  2015-08-25       Impact factor: 79.321

Review 2.  Systemic Therapy for Metastatic Renal-Cell Carcinoma.

Authors:  Toni K Choueiri; Robert J Motzer
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

Review 3.  Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs.

Authors:  Yangzom D Bhutia; Ellappan Babu; Sabarish Ramachandran; Vadivel Ganapathy
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

4.  Expression of NHE-3 in the apical membrane of rat renal proximal tubule and thick ascending limb.

Authors:  M Amemiya; J Loffing; M Lötscher; B Kaissling; R J Alpern; O W Moe
Journal:  Kidney Int       Date:  1995-10       Impact factor: 10.612

5.  Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.

Authors:  Umberto Capitanio; Carlo Terrone; Alessandro Antonelli; Andrea Minervini; Alessandro Volpe; Maria Furlan; Rayan Matloob; Federica Regis; Cristian Fiori; Francesco Porpiglia; Ettore Di Trapani; Monica Zacchero; Sergio Serni; Andrea Salonia; Marco Carini; Claudio Simeone; Francesco Montorsi; Roberto Bertini
Journal:  Eur Urol       Date:  2014-10-03       Impact factor: 20.096

Review 6.  Glucose transporters in cancer - from tumor cells to the tumor microenvironment.

Authors:  Pierre-Benoit Ancey; Caroline Contat; Etienne Meylan
Journal:  FEBS J       Date:  2018-06-25       Impact factor: 5.542

7.  Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.

Authors:  Jason X Cheng; Maria Tretiakova; Can Gong; Saptarshi Mandal; Thomas Krausz; Jerome B Taxy
Journal:  Mod Pathol       Date:  2008-03-07       Impact factor: 7.842

8.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study.

Authors:  Melina Arnold; Nirmala Pandeya; Graham Byrnes; Prof Andrew G Renehan; Gretchen A Stevens; Prof Majid Ezzati; Jacques Ferlay; J Jaime Miranda; Isabelle Romieu; Rajesh Dikshit; David Forman; Isabelle Soerjomataram
Journal:  Lancet Oncol       Date:  2014-11-26       Impact factor: 41.316

9.  Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3.

Authors:  L Chen; C Hong; E C Chen; S W Yee; L Xu; E U Almof; C Wen; K Fujii; S J Johns; D Stryke; T E Ferrin; J Simko; X Chen; J F Costello; K M Giacomini
Journal:  Pharmacogenomics J       Date:  2012-01-10       Impact factor: 3.550

10.  The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.

Authors:  Damien Ambrosetti; Maeva Dufies; Bérengère Dadone; Matthieu Durand; Delphine Borchiellini; Jean Amiel; Jacques Pouyssegur; Nathalie Rioux-Leclercq; Gilles Pages; Fanny Burel-Vandenbos; Nathalie M Mazure
Journal:  PLoS One       Date:  2018-02-26       Impact factor: 3.240

View more
  2 in total

1.  Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma.

Authors:  Thomas C Whisenant; Sanjay K Nigam
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

2.  Potential Use of CTCs as Biomarkers in Renal Cancer Patients.

Authors:  Joanna Bialek; Andreas Wencker; Felix Kawan; Stefan Yankulov; Paolo Fornara; Gerit Theil
Journal:  Life (Basel)       Date:  2022-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.